flurpiridaz f-18 · Ge Hlthcare · NDA 215168
Flyrcado
Earliest generic entry, as listed
13 May 2042
Blocked by patent: US 12527884.
Listed patents · 5 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 12527884 | product, use U-4406 | 13 May 2042 |
| US 9687571 | product, use U-4011 | 1 Nov 2032 |
| US 8936777 | use U-4011 | 30 Jun 2031 |
| US 9603951 | use U-4011 | 2 May 2031 |
| US 8226929 | use U-4011 | 21 Jun 2028 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 27 Sep 2029 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 215168 · 001 · RLD | solution, intravenous | 5-55mCi/ML | 13 May 2042 |
Expired or delisted (2)
- US 7344702 · substance · 26 May 2026
- US 9161997 · substance, product, use U-4011 · 4 Feb 2026